| |
| |
|
| Insider
Information: |
Morneau Michael |
| Relationship: |
VP, Finance and Admini... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
116,062 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,308,172 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,062 |
|
|
| Total
Value |
$9,308,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
VP Finance & CAO |
2013-09-11 |
0 |
|
0 |
Premium* |
|
|
Viking Therapeutics, Inc. |
VKTX |
VP, Finance and Admini... |
2021-01-19 |
116,062 |
2015-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2021-01-19 |
4 |
D |
$6.68 |
$11,256 |
D/D |
(1,685) |
116,062 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2021-01-04 |
4 |
D |
$5.80 |
$15,886 |
D/D |
(2,739) |
117,747 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,334 |
120,486 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2020-09-15 |
4 |
D |
$6.25 |
$9,731 |
D/D |
(1,557) |
97,873 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2020-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
99,430 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2020-01-19 |
4 |
D |
$7.18 |
$14,676 |
D/D |
(2,044) |
92,840 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2019-01-19 |
4 |
D |
$8.78 |
$17,946 |
D/D |
(2,044) |
91,991 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2018-05-31 |
4 |
S |
$9.25 |
$199,347 |
D/D |
(21,551) |
94,035 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
VP, Finance and Administration |
• – – |
2018-05-04 |
4 |
D |
$4.22 |
$32,140 |
D/D |
(7,616) |
94,035 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
101,651 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-05-04 |
4 |
D |
$1.34 |
$10,977 |
D/D |
(8,192) |
80,604 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-05-04 |
4 |
A |
$9.49 |
$98,734 |
D/D |
10,404 |
77,404 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
67,000 |
67,000 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAO |
• – – |
2013-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,070) |
0 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAO |
• – – |
2013-07-11 |
4 |
AS |
$9.75 |
$195,000 |
D/D |
(20,000) |
12,545 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAO |
• – – |
2013-07-11 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
32,545 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAO |
• – – |
2013-05-14 |
4 |
AS |
$7.75 |
$155,000 |
D/D |
(20,000) |
10,635 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAO |
• – – |
2013-05-14 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
30,635 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
VP Finance & CAOOfficer |
• – – |
2011-04-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,429 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
